Literature DB >> 20969863

Reprogramming of cell junction modules during stepwise epithelial to mesenchymal transition and accumulation of malignant features in vitro in a prostate cell model.

Xi-song Ke1, Wen-cheng Li, Randi Hovland, Yi Qu, Run-hui Liu, Emmet McCormack, Frits Thorsen, Jan Roger Olsen, Anders Molven, Ira Kogan-Sakin, Varda Rotter, Lars A Akslen, Anne Margrete Oyan, Karl-Henning Kalland.   

Abstract

Epithelial to mesenchymal transition (EMT) is pivotal in tumor metastasis. Our previous work reported an EMT model based on primary prostate epithelial cells (EP156T) which gave rise to cells with mesenchymal phenotype (EPT1) without malignant transformation. To promote prostate cell transformation, cells were maintained in saturation density cultures to select for cells overriding quiescence. Foci formed repeatedly following around 8 weeks in confluent EPT1 monolayers. Only later passage EPT1, but not EP156T cells of any passage, could form foci. Cells isolated from the foci were named EPT2 and formed robust colonies in soft agar, a malignant feature present neither in EP156T nor in EPT1 cells. EPT2 cells showed additional malignant traits in vitro, including higher ability to proliferate following confluence, higher resistance to apoptosis and lower dependence on exogenous growth factors than EP156T and EPT1 cells. Microarray profiling identified gene sets, many of which belong to cell junction modules, that changed expression from EP156T to EPT1 cells and continued to change from EPT1 to EPT2 cells. Our findings provide a novel stepwise cell culture model in which EMT emerges independently of transformation and is associated with subsequent accumulation of malignant features in prostate cells. Reprogramming of cell junction modules is involved in both steps.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20969863     DOI: 10.1016/j.yexcr.2010.10.009

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

1.  Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.

Authors:  Cheng Yang; Regina Fischer-Kešo; Tanja Schlechter; Philipp Ströbel; Alexander Marx; Ilse Hofmann
Journal:  Tumour Biol       Date:  2015-07-04

Review 2.  In vivo animal models for studying brain metastasis: value and limitations.

Authors:  Inderjit Daphu; Terje Sundstrøm; Sindre Horn; Peter C Huszthy; Simone P Niclou; Per Ø Sakariassen; Heike Immervoll; Hrvoje Miletic; Rolf Bjerkvig; Frits Thorsen
Journal:  Clin Exp Metastasis       Date:  2013-01-16       Impact factor: 5.150

3.  Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.

Authors:  Xi-Song Ke; Yi Qu; Yang Cheng; Wen-Cheng Li; Varda Rotter; Anne Margrete Øyan; Karl-Henning Kalland
Journal:  BMC Genomics       Date:  2010-11-25       Impact factor: 3.969

4.  p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model.

Authors:  Jan Roger Olsen; Anne Margrete Oyan; Kari Rostad; Margrete R Hellem; Jie Liu; Lisha Li; David R Micklem; Hallvard Haugen; James B Lorens; Varda Rotter; Xi-Song Ke; Biaoyang Lin; Karl-Henning Kalland
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

5.  An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells.

Authors:  Waqas Azeem; Margrete Reime Hellem; Jan Roger Olsen; Yaping Hua; Kristo Marvyin; Yi Qu; Biaoyang Lin; Xisong Ke; Anne Margrete Øyan; Karl-Henning Kalland
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

6.  Meta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression.

Authors:  Christian J Gröger; Markus Grubinger; Thomas Waldhör; Klemens Vierlinger; Wolfgang Mikulits
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

7.  First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma.

Authors:  Oystein Helland; Mihaela Popa; Olav K Vintermyr; Anders Molven; Bjørn Tore Gjertsen; Line Bjørge; Emmet McCormack
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

8.  Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.

Authors:  Steven H Lin; Jing Wang; Pierre Saintigny; Chia-Chin Wu; Uma Giri; Jing Zhang; Toshi Menju; Lixia Diao; Lauren Byers; John N Weinstein; Kevin R Coombes; Luc Girard; Ritsuko Komaki; Ignacio I Wistuba; Hiroshi Date; John D Minna; John V Heymach
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

9.  Synergistic chromatin repression of the tumor suppressor gene RARB in human prostate cancers.

Authors:  Céline Moison; Fanny Assemat; Antoine Daunay; Jörg Tost; Anne-Laure Guieysse-Peugeot; Paola B Arimondo
Journal:  Epigenetics       Date:  2014-02-03       Impact factor: 4.528

10.  Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.

Authors:  Jan Roger Olsen; Waqas Azeem; Margrete Reime Hellem; Kristo Marvyin; Yaping Hua; Yi Qu; Lisha Li; Biaoyang Lin; Xi- Song Ke; Anne Margrete Øyan; Karl- Henning Kalland
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.